AI assistant
AMICUS THERAPEUTICS, INC. — Director's Dealing 2018
Jan 25, 2018
31523_dirs_2018-01-25_2851096b-1f36-478e-89ad-b75012ac905e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2018-01-23
Reporting Person: Barth Jay (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-01-23 | Common Stock | M | 20000 | $2.29 | Acquired | 105409 | Direct |
| 2018-01-23 | Common Stock | S | 20000 | $16.80 | Disposed | 85409 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-01-23 | Stock Options (right to buy) | $2.29 | M | 20000 | Disposed | 2024-03-03 | Common Stock (20000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 125 | Indirect |
Footnotes
F1: The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2017.
F2: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vested on March 3, 2015. The remaining options vest and become exercisable in a series of thirty-five successive equal monthly installments, beginning on April 1, 2015, with the final installment vesting on March 1, 2018.